Table 2.

HIV testing among patients tested for gonorrhea (GC) or chlamydia (CT) for the 7-month periods before and after implementation of the best practice advisory (BPA)

	Pre-implementation (N = 2,224)		Post-implementation (N = 2,281)		Odds Ratio (OR) for HIV Testing Post vs. Pre-implementation	p-value
	GC and/or CT with HIV testing	GC and/or CT without HIV testing	GC and/or CT with HIV testing	GC and/or CT without HIV testing
	n (%)	n (%)	n (%)	n (%)	OR (95% CI)
Age
18-24	543 (59.2%)	375 (40.8%)	620 (67.0%)	306 (33.0%)	1.40 (1.16, 1.69)	<0.01
25-34	468 (56.1%)	366 (43.9%)	571 (67.8%)	271 (32.2%)	1.65 (1.35, 2.01)	<0.01
35-44	149 (52.5%)	135 (47.5%)	193 (64.3%)	107 (35.7%)	1.63 (1.17, 2.28)	<0.01
45-54	65 (51.6%)	61 (48.4%)	83 (67.5%)	40 (32.5%)	1.95 (1.16, 3.26)	0.01
55+	29 (46.8%)	33 (53.2%)	54 (60.0%)	36 (40.0%)	1.71 (0.89, 3.28)	0.11
Sex at Birth
Female	867 (52.8%)	775 (47.2%)	1077 (63.3%)	624 (36.7%)	1.54 (1.34, 1.77)	<0.01
Male	387 (66.5%)	195 (33.5%)	444 (76.6%)	136 (23.4%)	1.65 (1.27, 2.13)	<0.01
Race/Ethnicity
Non-Hispanic Black	1178 (56.8%)	896 (43.2%)	1408 (67.0%)	695 (33.0%)	1.54 (1.36, 1.75)	<0.01
Non-Hispanic White	17 (34.0%)	33 (66.0%)	34 (57.6%)	25 (42.4%)	2.64 (1.21, 5.76)	0.02
Hispanic	37 (58.7%)	26 (41.3%)	45 (64.3%)	25 (35.7%)	1.27 (0.63, 2.55)	0.51
Other	16 (59.3%)	11 (40.7%)	22 (66.7%)	11 (33.3%)	1.38 (0.48, 3.95)	0.55
Insurance
Private	208 (52.8%)	186 (47.2%)	246 (64.4%)	136 (35.6%)	1.62 (1.21, 2.16)	<0.01
Medicaid/Medicare	802 (56.4%)	619 (43.6%)	962 (65.8%)	500 (34.2%)	1.49 (1.28, 1.73)	<0.01
Self-Pay	244 (59.7%)	165 (40.3%)	313 (71.6%)	124 (28.4%)	1.71 (1.28, 2.27)	<0.01
Total	1254 (56.4%)	970 (43.6%)	1521 (66.7%)	760 (33.3%)	1.55 (1.37, 1.75)	<0.01